Cargando…

Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease

BACKGROUND: Chronic pain is often difficult to manage in autosomal dominant polycystic kidney disease (ADPKD) patients and sometimes even leads to nephrectomy. We analyzed the long-term efficacy of our innovative multidisciplinary protocol to treat chronic refractory pain that aims to preserve kidne...

Descripción completa

Detalles Bibliográficos
Autores principales: van Luijk, Franka, Gansevoort, Ron T, Blokzijl, Hans, Groen, Gerbrand J, de Haas, Robbert J, Leliveld, Anna M, Meijer, Esther, Perdok, Joke M, Stellema, Ruud, Wolff, Andreas P, Casteleijn, Niek F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976741/
https://www.ncbi.nlm.nih.gov/pubmed/35512573
http://dx.doi.org/10.1093/ndt/gfac158
_version_ 1784899150054162432
author van Luijk, Franka
Gansevoort, Ron T
Blokzijl, Hans
Groen, Gerbrand J
de Haas, Robbert J
Leliveld, Anna M
Meijer, Esther
Perdok, Joke M
Stellema, Ruud
Wolff, Andreas P
Casteleijn, Niek F
author_facet van Luijk, Franka
Gansevoort, Ron T
Blokzijl, Hans
Groen, Gerbrand J
de Haas, Robbert J
Leliveld, Anna M
Meijer, Esther
Perdok, Joke M
Stellema, Ruud
Wolff, Andreas P
Casteleijn, Niek F
author_sort van Luijk, Franka
collection PubMed
description BACKGROUND: Chronic pain is often difficult to manage in autosomal dominant polycystic kidney disease (ADPKD) patients and sometimes even leads to nephrectomy. We analyzed the long-term efficacy of our innovative multidisciplinary protocol to treat chronic refractory pain that aims to preserve kidney function by applying among other sequential nerve blocks. METHODS: Patients were eligible if pain was present ≥3 months with a score of ≥50 on a visual analog scale (VAS) of 100, was negatively affecting quality of life and if there had been insufficient response to previous therapies, including opioid treatment. Treatment options were, in order, analgesics, cyst aspiration and fenestration, nerve blocks and nephrectomy. RESULTS: A total of 101 patients were assessed in our clinic (mean age 50 ± 11 years, 65.3% females). Eight patients were treated with medication, 6 by cyst aspiration or fenestration, 63 by nerve blocks and 6 received surgery as the first treatment option. Overall, 76.9% experienced a positive effect on pain complaints shortly after treatment. The VAS score was reduced from 60/100 to 20/100 (P < 0.001) and patients decreased their number of nonopioid and opioid analgesics significantly (P < 0.001, P = 0.01, respectively). A substantial number of the patients (n = 51) needed additional treatment. At the end of follow-up in only 13 patients (12.9%) was surgical intervention necessary: 11 nephrectomies (of which 10 were in patients already on kidney function replacement treatment), 1 liver transplantation and 1 partial hepatectomy. After a median follow-up of 4.5 years (interquartile range 2.5–5.3), 69.0% of the patients still had fewer pain complaints. CONCLUSIONS: These data indicate that our multidisciplinary treatment protocol appears effective in reducing pain in the majority of patients with chronic refractory pain, while postponing or even avoiding in most patients surgical interventions such as nephrectomy in most patients.
format Online
Article
Text
id pubmed-9976741
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-99767412023-03-02 Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease van Luijk, Franka Gansevoort, Ron T Blokzijl, Hans Groen, Gerbrand J de Haas, Robbert J Leliveld, Anna M Meijer, Esther Perdok, Joke M Stellema, Ruud Wolff, Andreas P Casteleijn, Niek F Nephrol Dial Transplant Original Article BACKGROUND: Chronic pain is often difficult to manage in autosomal dominant polycystic kidney disease (ADPKD) patients and sometimes even leads to nephrectomy. We analyzed the long-term efficacy of our innovative multidisciplinary protocol to treat chronic refractory pain that aims to preserve kidney function by applying among other sequential nerve blocks. METHODS: Patients were eligible if pain was present ≥3 months with a score of ≥50 on a visual analog scale (VAS) of 100, was negatively affecting quality of life and if there had been insufficient response to previous therapies, including opioid treatment. Treatment options were, in order, analgesics, cyst aspiration and fenestration, nerve blocks and nephrectomy. RESULTS: A total of 101 patients were assessed in our clinic (mean age 50 ± 11 years, 65.3% females). Eight patients were treated with medication, 6 by cyst aspiration or fenestration, 63 by nerve blocks and 6 received surgery as the first treatment option. Overall, 76.9% experienced a positive effect on pain complaints shortly after treatment. The VAS score was reduced from 60/100 to 20/100 (P < 0.001) and patients decreased their number of nonopioid and opioid analgesics significantly (P < 0.001, P = 0.01, respectively). A substantial number of the patients (n = 51) needed additional treatment. At the end of follow-up in only 13 patients (12.9%) was surgical intervention necessary: 11 nephrectomies (of which 10 were in patients already on kidney function replacement treatment), 1 liver transplantation and 1 partial hepatectomy. After a median follow-up of 4.5 years (interquartile range 2.5–5.3), 69.0% of the patients still had fewer pain complaints. CONCLUSIONS: These data indicate that our multidisciplinary treatment protocol appears effective in reducing pain in the majority of patients with chronic refractory pain, while postponing or even avoiding in most patients surgical interventions such as nephrectomy in most patients. Oxford University Press 2022-05-25 /pmc/articles/PMC9976741/ /pubmed/35512573 http://dx.doi.org/10.1093/ndt/gfac158 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
van Luijk, Franka
Gansevoort, Ron T
Blokzijl, Hans
Groen, Gerbrand J
de Haas, Robbert J
Leliveld, Anna M
Meijer, Esther
Perdok, Joke M
Stellema, Ruud
Wolff, Andreas P
Casteleijn, Niek F
Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease
title Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease
title_full Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease
title_fullStr Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease
title_full_unstemmed Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease
title_short Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease
title_sort multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976741/
https://www.ncbi.nlm.nih.gov/pubmed/35512573
http://dx.doi.org/10.1093/ndt/gfac158
work_keys_str_mv AT vanluijkfranka multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT gansevoortront multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT blokzijlhans multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT groengerbrandj multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT dehaasrobbertj multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT leliveldannam multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT meijeresther multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT perdokjokem multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT stellemaruud multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT wolffandreasp multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease
AT casteleijnniekf multidisciplinarymanagementofchronicrefractorypaininautosomaldominantpolycystickidneydisease